Insufficient scRNA-seq data for expression of SPRED3 at single-cell level.
Insufficient scRNA-seq data for expression of SPRED3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 721.54 | 2631 / 2642 | 99% | 7.56 | 696 / 705 |
thymus | 92% | 148.69 | 598 / 653 | 71% | 1.78 | 429 / 605 |
skin | 99% | 257.70 | 1783 / 1809 | 57% | 3.73 | 269 / 472 |
breast | 75% | 123.79 | 344 / 459 | 80% | 2.10 | 889 / 1118 |
esophagus | 73% | 108.19 | 1049 / 1445 | 79% | 2.16 | 144 / 183 |
lung | 71% | 138.66 | 409 / 578 | 67% | 1.98 | 773 / 1155 |
prostate | 96% | 241.11 | 235 / 245 | 38% | 0.61 | 192 / 502 |
pancreas | 40% | 54.92 | 132 / 328 | 91% | 3.91 | 162 / 178 |
uterus | 74% | 107.75 | 126 / 170 | 45% | 1.26 | 207 / 459 |
kidney | 70% | 199.71 | 62 / 89 | 41% | 0.97 | 371 / 901 |
bladder | 67% | 130.19 | 14 / 21 | 43% | 0.98 | 219 / 504 |
adrenal gland | 34% | 76.60 | 87 / 258 | 68% | 6.83 | 157 / 230 |
intestine | 64% | 88.82 | 622 / 966 | 36% | 0.90 | 188 / 527 |
ovary | 36% | 41.72 | 64 / 180 | 63% | 1.89 | 272 / 430 |
stomach | 44% | 71.82 | 157 / 359 | 52% | 1.21 | 149 / 286 |
blood vessel | 93% | 525.38 | 1243 / 1335 | 0% | 0 | 0 / 0 |
adipose | 54% | 78.70 | 655 / 1204 | 0% | 0 | 0 / 0 |
muscle | 50% | 125.93 | 405 / 803 | 0% | 0 | 0 / 0 |
heart | 38% | 82.44 | 331 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 0.35 | 10 / 45 |
liver | 8% | 18.23 | 17 / 226 | 10% | 0.23 | 40 / 406 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.30 | 4 / 29 |
spleen | 8% | 7.22 | 19 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 7% | 7.47 | 67 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.11 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902747 | Biological process | negative regulation of lens fiber cell differentiation |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0005886 | Cellular component | plasma membrane |
GO_0019901 | Molecular function | protein kinase binding |
Gene name | SPRED3 |
Protein name | Sprouty-related, EVH1 domain-containing protein 3 (Spred-3) HCG1647763 (Sprouty related EVH1 domain containing 3) Sprouty related EVH1 domain containing 3 Sprouty-related, EVH1 domain containing 3 |
Synonyms | EVE-3 hCG_1647763 |
Description | FUNCTION: Tyrosine kinase substrate that inhibits growth-factor-mediated activation of MAP kinase (By similarity). Inhibits fibroblast growth factor (FGF)-induced retinal lens fiber differentiation, probably by inhibiting FGF-mediated phosphorylation of ERK1/2 (By similarity). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (By similarity). . |
Accessions | B9EKV1 K7EPT9 ENST00000586301.6 [Q2MJR0-1] ENST00000586958.1 ENST00000587013.6 K7EPU5 K7EKP4 Q2MJR0 ENST00000691638.1 [Q2MJR0-1] ENST00000587947.5 ENST00000338502.8 [Q2MJR0-1] |